The Times Australia
News From Asia

.

Immuno Cure Completed US$12M First Close of Series A Financing, led by AEF GBA Fund managed by Gobi Partners GBA

Advancing DNA vaccines & Immunotherapies for HIV, Cancers & Infectious Diseases

HONG KONG SAR - Media OutReach - 27 July 2023 - Immuno Cure BioTech ("Immuno Cure") is pleased to announce today that it has closed the US$12 million tranche in the US$27 million Series A fundraising round.

Led by the AEF Greater Bay Area Fund that Gobi Partners GBA ("Gobi GBA") manages, this round will be used to accelerate the development of DNA vaccines and antibodies, as well as to prepare for an initial public offering ("IPO") in Hong Kong.

Immuno Cure focuses on research and development of immunotherapies for cancers, inflammatory and infectious diseases based on its patented "PD-1-enhanced DNA Vaccine Platform" and "Anti-Δ42PD1 Antibody Platform" with two DNA vaccine candidates, ICVAX and ICCOV, currently in clinical trials.

Dr. Xia JIN, CEO of Immuno Cure, said, "This funding round is a landmark in Immuno Cure's business expansion. We are honored to receive strong support from the AEF Greater Bay Area Fund, which affirms the recognition of our scientific merits and R&D achievements. Immuno Cure will continue to be at the frontier of DNA medicines, antibodies and innovative immunotherapies, conducting R&D on novel and effective vaccine technologies to enhance our arsenal against cancers and infectious diseases."

Mr. Chibo Tang, Managing Partner of Gobi Partners GBA, shared, "Infectious diseases are a universal issue that has threatened global public health for many years and has further been highlighted by COVID-19. We believe that Immuno Cure's technologies have innovative applications of immunotherapies for not only infectious diseases but also cancers and other ailments down the line, and have the potential to truly change the world."

ICVAX, a therapeutic DNA vaccine candidate against HIV/AIDS, was developed with an aim to induce broadly reactive polyfunctional viral-specific T cells to achieve functional cure in HIV/AIDS. The Phase I clinical trial of ICVAX, which is underway in Shenzhen, is designed as a randomized, double-blinded, placebo-controlled study to evaluate the safety and immunogenicity of ICVAX in a total of 45 stable HIV/AIDS patient volunteers under antiretroviral therapy.

ICCOV, a preventive COVID-19 DNA vaccine candidate, has entered the Phase IIa clinical trial in Hong Kong, which is designed as an open-label study to evaluate the immunogenicity and safety of ICCOV as a booster vaccine in a total of 60 healthy adult volunteers between 18 and 75 years of age.

Furthermore, Immuno Cure has made significant achievements on the Anti-Δ42PD1 Antibody platform, which utilizes antibodies targeting Δ42PD1, a recently discovered isoformic programmed cell death protein 1 (PD-1), for the restoration of function of killer T cells, a type of immune cells essential for killing cancer cells, for the treatment of cancers such as liver cancer and colorectal cancer.

Hashtag: #ImmunoCure #醫克生物 #医克生物

The issuer is solely responsible for the content of this announcement.

About Immuno Cure

Immuno Cure is a clinical stage biotechnology group based in the Hong Kong Science Park, focusing on research and development of immunotherapies for cancers, inflammatory and infectious diseases based on its patented PD-1-enhanced DNA vaccine and Anti-Δ42PD1 Antibody platforms; with two DNA vaccine candidates currently in clinical trials.

Official Website:
Official Linkedin:

About Gobi GBA

Gobi Partners GBA (Gobi GBA) was established in 2016 as a part of the leading Pan-Asian venture capital platform Gobi Partners. Gobi GBA is the sole general partner (GP) of the Alibaba Hong Kong Entrepreneurs Fund (AEF) as well as the AEF Greater Bay Area Fund (AEF GBA Fund), and has formed strategic partnerships with other renowned financial institutions such as HSBC and Hang Seng Bank.

As of 2023, Gobi GBA has invested in over 70 start-ups across the Greater Bay Area, and has fostered the growth of 7 unicorns including Airwallex, Amber, Animoca Brands, GoGoX, Prenetics, and more.

Official Website:
Official Linkedin:

Times Magazine

Choosing the Right Legal Aid Lawyer in Sutherland Shire: Key Considerations

Legal aid services play an essential role in ensuring access to justice for all. For people in the Sutherland Shire who may not have the financial means to pay for private legal assistance, legal aid ensures that everyone has access to representa...

Watercolor vs. Oil vs. Digital: Which Medium Fits Your Pet's Personality?

When it comes to immortalizing your pet’s unique personality in art, choosing the right medium is essential. Each artistic medium, whether watercolor, oil, or digital, has distinct qualities that can bring out the spirit of your furry friend in dif...

DIY Is In: How Aussie Parents Are Redefining Birthday Parties

When planning his daughter’s birthday, Rich opted for a DIY approach, inspired by her love for drawing maps and giving clues. Their weekend tradition of hiding treats at home sparked the idea, and with a pirate ship playground already chosen as t...

When Touchscreens Turn Temperamental: What to Do Before You Panic

When your touchscreen starts acting up, ignoring taps, registering phantom touches, or freezing entirely, it can feel like your entire setup is falling apart. Before you rush to replace the device, it’s worth taking a deep breath and exploring what c...

Why Social Media Marketing Matters for Businesses in Australia

Today social media is a big part of daily life. All over Australia people use Facebook, Instagram, TikTok , LinkedIn and Twitter to stay connected, share updates and find new ideas. For businesses this means a great chance to reach new customers and...

Building an AI-First Culture in Your Company

AI isn't just something to think about anymore - it's becoming part of how we live and work, whether we like it or not. At the office, it definitely helps us move faster. But here's the thing: just using tools like ChatGPT or plugging AI into your wo...

The Times Features

From Farms to Festivals: How Regional NSW Is Repurposing Shipping Containers

Regional NSW communities are repurposing containers for farms, tourism, and events Farmers and small businesses use them as cost-effective, flexible infrastructure Festivals ...

What a Mobile Speech Pathologist Really Does for Late Talkers

As a parent, it’s natural to keep a close eye on your child’s development. When your toddler isn’t using as many words as their peers, the internet can feel like a rabbit hole ...

Benefits of Tree Pruning for a Thriving Australian Garden

Tree pruning is an essential aspect of garden maintenance that often doesn't get the attention it deserves. It's a practice that involves the selective removal of certain parts...

What is psychosocial therapy? And why is the government thinking about adding it to Medicare for kids?

The government is considering new, bulk-billed health checks for three-year-olds, to pick up developmental concerns and refer kids that might need additional support. The de...

Detect Hidden Water Leaks Fast: Don’t Ignore Hot Water System Leaks

Detecting water leaks early is crucial for preventing extensive damage to your home. Among the various parts of a home’s plumbing system, hot water systems are particularly suscept...

Why do hamstring injuries happen so often and how can they be prevented?

In a recent clash against the Melbourne Storm, the Brisbane Broncos endured a nightmare rarely seen in professional sport — three players tore their hamstrings[1] in a single g...